NCT01395030View on ClinicalTrials.gov

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 15, 2011

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2018

Conditions
Adult Hepatocellular CarcinomaLocalized Resectable Adult Liver Carcinoma
Interventions
DIAGNOSTIC_TEST

Computed Tomography

Undergo FCH PET/CT

DRUG

18F-fluoromethylcholine

Undergo FCH PET/CT

DIAGNOSTIC_TEST

Positron Emission Tomography

Undergo FCH PET/CT

Trial Locations (1)

96813

University of Hawaii Cancer Center, Honolulu

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Queen's Medical Center

OTHER

NCT01395030 - PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection | Biotech Hunter | Biotech Hunter